Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer. [PDF]
, 2018 BACKGROUND: Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA.
Bazzan, Anthony J. +4 more
core +2 more sources
Iraqi Journal of Pharmaceutical SciencesOral anticancer medicines are frequently administered to patients with cancer. Regrettably, many medications are administered without appropriate recommendations about handling practices.
Mayyadah Q. Kadhim , Dheyaa J. Kadhim
doaj +1 more source
Anticancer Activities of Polygonum odoratum Lour.: A Systematic Review
Frontiers in Pharmacology, 2022 Cancers are a potential cause of death worldwide and represent a massive burden for healthcare systems. Treating cancers requires substantial resources, including skilled personnel, medications, instruments, and funds.
Thanut Khuayjarernpanishk +17 more
doaj +1 more source
Adherence to adjuvant therapy in post-menopausal breast cancer patients: A review [PDF]
, 2011 This is the post-print version of the Article. The official published version can be accessed from the link below - Copyright @ 2012 John Wiley & Sons, IncThis review aimed to address the concept of adherence to adjuvant therapy in post-menopausal women.
Banning, M
core +1 more source
Frontiers in Pharmacology, 2019 The idiosyncratic nature of drug-induced liver injury (DILI) represents a current challenge for drug developers, regulators and clinicians. The myriad of agents (including medications, herbals, and dietary supplements) with recognized DILI potential not ...
Emanuel Raschi, Fabrizio De Ponti
doaj +1 more source
Addressing cost‐related nonadherence to oral anticancer medications through health policy reform: Challenges and opportunities [PDF]
Cancer, 2020 In this editorial, the authors discuss several of Dean et al's proposed interventions aimed at payers and the pharmaceutical supply chain and highlight the challenges and opportunities for improving patient access to oral anticancer medications through system reform.
Shelley A. Jazowski, Stacie B. Dusetzina
openaire +2 more sources
Why individual‐level interventions are not enough: Systems‐level determinants of oral anticancer medication adherence [PDF]
Cancer, 2020 Nonadherence to oral anticancer medications (OAMs) in the United States is as low as 33% for some cancers. The reasons for nonadherence to these lifesaving medications are multifactorial, yet the majority of studies focus on patient‐level factors influencing uptake and adherence.
Lorraine T. Dean +3 more
openaire +2 more sources
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors
Acta Pharmaceutica, 2023 Treatment adherence is crucial for optimal outcomes in advanced breast cancer, but can be challenging due to various factors, i.e. patients’ attitudes and behavior upon diagnosis, and complex therapies with high adverse effect rates.
Baković Matea +8 more
doaj +1 more source
Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]
, 2020 Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth +2 more
core
Antidiabetic effect of Tibetan medicine Tang-Kang-Fu-San on high-fat diet and streptozotocin-induced type 2 diabetic rats [PDF]
, 2017 The aim of this study was to investigate the antidiabetic effects of a Tibetan medicine, Tang-Kang-Fu-San (TKFS), on experimental type 2 diabetes mellitus (T2DM) rats and to explore its underlying mechanisms.
Duan, Bailu +8 more
core +3 more sources